ATE273313T1 - Verfahren zur herstellung von reinen phosphatiden und deren verwendung in der kosmetik, im pharmazeutischen gebiet und im bereich der nahrungsmittel - Google Patents

Verfahren zur herstellung von reinen phosphatiden und deren verwendung in der kosmetik, im pharmazeutischen gebiet und im bereich der nahrungsmittel

Info

Publication number
ATE273313T1
ATE273313T1 AT02002360T AT02002360T ATE273313T1 AT E273313 T1 ATE273313 T1 AT E273313T1 AT 02002360 T AT02002360 T AT 02002360T AT 02002360 T AT02002360 T AT 02002360T AT E273313 T1 ATE273313 T1 AT E273313T1
Authority
AT
Austria
Prior art keywords
phosphatides
field
cosmetics
production
pure
Prior art date
Application number
AT02002360T
Other languages
English (en)
Inventor
Guenter Kirschner
Giampaolo Menon
Susanna Vaccaro
Original Assignee
Fidia Farmaceutici
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=11452205&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE273313(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Fidia Farmaceutici filed Critical Fidia Farmaceutici
Application granted granted Critical
Publication of ATE273313T1 publication Critical patent/ATE273313T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic System
    • C07F9/02—Phosphorus compounds
    • C07F9/06—Phosphorus compounds without P—C bonds
    • C07F9/08—Esters of oxyacids of phosphorus
    • C07F9/09—Esters of phosphoric acids
    • C07F9/10—Phosphatides, e.g. lecithin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/55—Phosphorus compounds
    • A61K8/553—Phospholipids, e.g. lecithin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/16—Emollients or protectives, e.g. against radiation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P13/00—Preparation of nitrogen-containing organic compounds
    • C12P13/04—Alpha- or beta- amino acids
    • C12P13/06—Alanine; Leucine; Isoleucine; Serine; Homoserine
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P9/00—Preparation of organic compounds containing a metal or atom other than H, N, C, O, S or halogen
AT02002360T 2001-02-09 2002-01-31 Verfahren zur herstellung von reinen phosphatiden und deren verwendung in der kosmetik, im pharmazeutischen gebiet und im bereich der nahrungsmittel ATE273313T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT2001PD000031A ITPD20010031A1 (it) 2001-02-09 2001-02-09 Procedimento per la preparazione di fosfatidi puri e loro impiego in campo cosmetico, farmaceutico ed alimentare.

Publications (1)

Publication Number Publication Date
ATE273313T1 true ATE273313T1 (de) 2004-08-15

Family

ID=11452205

Family Applications (1)

Application Number Title Priority Date Filing Date
AT02002360T ATE273313T1 (de) 2001-02-09 2002-01-31 Verfahren zur herstellung von reinen phosphatiden und deren verwendung in der kosmetik, im pharmazeutischen gebiet und im bereich der nahrungsmittel

Country Status (16)

Country Link
EP (1) EP1231213B1 (de)
JP (2) JP2002253288A (de)
AT (1) ATE273313T1 (de)
AU (1) AU766891B2 (de)
CA (1) CA2366705C (de)
CZ (1) CZ20032137A3 (de)
DE (1) DE60200895T2 (de)
DK (1) DK1231213T3 (de)
ES (1) ES2225662T3 (de)
HK (1) HK1049166B (de)
HU (1) HUP0303977A3 (de)
IT (1) ITPD20010031A1 (de)
NO (1) NO317429B1 (de)
PL (1) PL362845A1 (de)
RU (1) RU2289625C2 (de)
WO (1) WO2002064603A1 (de)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10142014B4 (de) * 2001-08-28 2004-11-11 Degussa Bioactives Deutschland Gmbh & Co. Kg Verfahren zur Herstellung von Phosphatidylserin
IL150240A (en) * 2002-06-16 2005-07-25 Lipogen Ltd Infant formula supplemented with phospholipids
DE102004002053A1 (de) * 2004-01-15 2005-08-04 Bioghurt Biogarde Gmbh & Co. Kg Verfahren zur Herstellung von Phosphatidylserin und dessen Reinigung durch Extraktion
US20050158835A1 (en) * 2004-01-21 2005-07-21 Su Chen Preparation of highly polyunsaturated fatty acid-containing phosphatidylserine and phosphatidic acid
JP2005318827A (ja) * 2004-05-07 2005-11-17 Nisshin Oillio Group Ltd セリンの回収方法
JP2007522259A (ja) * 2004-10-20 2007-08-09 ドゥサン コーポレーション ホスファチジルセリンを含有する皮膚保・改善用あるいは皮膚バリア機能強化用の組成物
ITPD20050164A1 (it) 2005-05-30 2006-11-30 Fidia Farmaceutici Processo per la preparazione e l'isolamento di fosfatidi
WO2008052126A2 (en) * 2006-10-25 2008-05-02 University Of Pittsburgh - Of The Commonwealth System Of Higher Education Ointment comprising phosphatidylserine as active agent for cancer treatment
RU2482186C2 (ru) * 2008-05-15 2013-05-20 Лодерс Кроклан Б.В. Способ получения фосфатидилсерина
US8546104B2 (en) * 2008-08-07 2013-10-01 Lipogen Ltd. Processes for the preparation of phosphatide salts
JP5432563B2 (ja) * 2009-03-31 2014-03-05 株式会社ファンケル ホスファチジルセリン含有カプセル及びカプセル充填用ホスファチジルセリン組成物
CN103074390A (zh) * 2011-11-02 2013-05-01 江南大学 一种酶法制备不含溶血磷脂和磷脂酸的磷脂酰丙醇的方法
ITPD20120021A1 (it) 2012-01-26 2013-07-27 Fidia Farmaceutici "nuove composizioni farmaceutiche contenenti fosfatidilserina e curcumina".

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6098995A (ja) * 1983-11-04 1985-06-01 Microbial Chem Res Found 光学活性３−（３，４−ジヒドロキシフエニル）セリン，およびその誘導体の製造法
US5700668A (en) * 1995-12-08 1997-12-23 Italfarmaco Sud S.P.A. Process for the industrial preparation of phosphatidylserine
DE19917249C2 (de) * 1999-02-26 2001-09-27 Meyer Lucas Gmbh & Co Verfahren zur Herstellung von Phosphatidylserin-Produkten
IT1311929B1 (it) * 1999-04-28 2002-03-20 Chemi Spa Procedimento per la preparazione di fosfatidilserine.

Also Published As

Publication number Publication date
ES2225662T3 (es) 2005-03-16
RU2003125183A (ru) 2005-03-20
DE60200895D1 (de) 2004-09-16
WO2002064603A1 (en) 2002-08-22
DK1231213T3 (da) 2004-12-06
EP1231213B1 (de) 2004-08-11
ITPD20010031A1 (it) 2002-08-09
HUP0303977A3 (en) 2011-01-28
DE60200895T2 (de) 2005-09-01
JP2007259866A (ja) 2007-10-11
CZ20032137A3 (cs) 2004-02-18
AU1006402A (en) 2002-08-15
NO20020019D0 (no) 2002-01-03
HUP0303977A2 (hu) 2004-03-29
EP1231213A1 (de) 2002-08-14
RU2289625C2 (ru) 2006-12-20
JP2002253288A (ja) 2002-09-10
PL362845A1 (en) 2004-11-02
CA2366705C (en) 2006-09-12
HK1049166A1 (en) 2003-05-02
CA2366705A1 (en) 2002-08-09
AU766891B2 (en) 2003-10-23
NO20020019L (no) 2002-08-12
HK1049166B (zh) 2005-04-22
NO317429B1 (no) 2004-10-25

Similar Documents

Publication Publication Date Title
ATE273313T1 (de) Verfahren zur herstellung von reinen phosphatiden und deren verwendung in der kosmetik, im pharmazeutischen gebiet und im bereich der nahrungsmittel
DE60018267D1 (de) Verfahren zur herstellung von käse
DE60320362D1 (de) Verfahren zur Herstellung von Dipeptiden
PT1226267E (pt) Processo para produzir um produto tripeptidos anti-hipertensores
DE69621663T2 (de) Verfahren zur Herstellung von Arachidonsäure
BRPI0509418A (pt) composição de bebida ácida e processo para a preparação de uma suspensão estável de um material protéico em uma bebida ácida
DE60232120D1 (de) Verfahren zur Herstellung von L-Lysin oder L-Arginin unter Verwendung methanolassimilierender Bakterien
BR0307350A (pt) Processo para a produção de queijo, e, queijo
DE3767182D1 (de) Phospholipidhaltige produkte, deren herstellung und verwendung.
DE602004022752D1 (de) Verfahren zur Herstellung von einem monodispersen Schaum , und dadurch hergestelltes Produkt
DE602004014805D1 (de) Verfahren zur herstellung von pharmazeutischen multiteilchenförmigen produkten
ATE204851T1 (de) Verfahren zur herstellung von retrovial protease hemmenden zwischenprodukten
DE69841553D1 (de) Verfahren zur herstellung von entölten phosphtiden
ATE83618T1 (de) Emulgiermittel.
ATE462709T1 (de) Methode zur herstellung von diazaphosphacyclen
BRPI0415857A (pt) método para preparar um composto, produto preparado por esse processo e composição que compreende o mesmo
ATE304298T1 (de) Verfahren zur herstellung von fleischprodukten
ATE253847T1 (de) Verfahren zur herstellung von biologischen geflügelprodukten
BRPI0410384A (pt) compostos, processo para a preparação desses compostos, composições farmacêuticas que comprendem os mesmos, método para o tratamento e/ou profilaxia de enfermidades que são moduladas por inibidores de ptp1b e sua utilização

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1231213

Country of ref document: EP